457 related articles for article (PubMed ID: 27628106)
1. Hepatocyte glutathione peroxidase-1 deficiency improves hepatic glucose metabolism and decreases steatohepatitis in mice.
Merry TL; Tran M; Dodd GT; Mangiafico SP; Wiede F; Kaur S; McLean CL; Andrikopoulos S; Tiganis T
Diabetologia; 2016 Dec; 59(12):2632-2644. PubMed ID: 27628106
[TBL] [Abstract][Full Text] [Related]
2. High-fat-fed obese glutathione peroxidase 1-deficient mice exhibit defective insulin secretion but protection from hepatic steatosis and liver damage.
Merry TL; Tran M; Stathopoulos M; Wiede F; Fam BC; Dodd GT; Clarke I; Watt MJ; Andrikopoulos S; Tiganis T
Antioxid Redox Signal; 2014 May; 20(14):2114-29. PubMed ID: 24252128
[TBL] [Abstract][Full Text] [Related]
3. Estrogen Signals Through Peroxisome Proliferator-Activated Receptor-γ Coactivator 1α to Reduce Oxidative Damage Associated With Diet-Induced Fatty Liver Disease.
Besse-Patin A; Léveillé M; Oropeza D; Nguyen BN; Prat A; Estall JL
Gastroenterology; 2017 Jan; 152(1):243-256. PubMed ID: 27658772
[TBL] [Abstract][Full Text] [Related]
4. Tcf7l2 in hepatocytes regulates de novo lipogenesis in diet-induced non-alcoholic fatty liver disease in mice.
Lee DS; An TH; Kim H; Jung E; Kim G; Oh SY; Kim JS; Chun HJ; Jung J; Lee EW; Han BS; Han DH; Lee YH; Han TS; Hur K; Lee CH; Kim DS; Kim WK; Park JW; Koo SH; Seong JK; Lee SC; Kim H; Bae KH; Oh KJ
Diabetologia; 2023 May; 66(5):931-954. PubMed ID: 36759348
[TBL] [Abstract][Full Text] [Related]
5. An oxidative stress paradox: time for a conceptual change?
Haas JT; Staels B
Diabetologia; 2016 Dec; 59(12):2514-2517. PubMed ID: 27695900
[TBL] [Abstract][Full Text] [Related]
6. T cell protein tyrosine phosphatase (TCPTP) deficiency in muscle does not alter insulin signalling and glucose homeostasis in mice.
Loh K; Merry TL; Galic S; Wu BJ; Watt MJ; Zhang S; Zhang ZY; Neel BG; Tiganis T
Diabetologia; 2012 Feb; 55(2):468-78. PubMed ID: 22124607
[TBL] [Abstract][Full Text] [Related]
7. Deficiency of glutathione peroxidase-1 and catalase attenuated diet-induced obesity and associated metabolic disorders.
Kim HR; Choi EJ; Kie JH; Lee JH; Seoh JY
Acta Diabetol; 2020 Feb; 57(2):151-161. PubMed ID: 31372751
[TBL] [Abstract][Full Text] [Related]
8. Genetic Ablation of STE20-Type Kinase MST4 Does Not Alleviate Diet-Induced MASLD Susceptibility in Mice.
Caputo M; Andersson E; Xia Y; Hou W; Cansby E; Erikson M; Lind DE; Hallberg B; Amrutkar M; Mahlapuu M
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397122
[TBL] [Abstract][Full Text] [Related]
9. Perilipin-2 promotes obesity and progressive fatty liver disease in mice through mechanistically distinct hepatocyte and extra-hepatocyte actions.
Orlicky DJ; Libby AE; Bales ES; McMahan RH; Monks J; La Rosa FG; McManaman JL
J Physiol; 2019 Mar; 597(6):1565-1584. PubMed ID: 30536914
[TBL] [Abstract][Full Text] [Related]
10. Genetic inactivation of the LIGHT (TNFSF14) cytokine in mice restores glucose homeostasis and diminishes hepatic steatosis.
Herrero-Cervera A; Vinué Á; Burks DJ; González-Navarro H
Diabetologia; 2019 Nov; 62(11):2143-2157. PubMed ID: 31388695
[TBL] [Abstract][Full Text] [Related]
11. Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in non-alcoholic fatty liver disease.
Dongiovanni P; Meroni M; Baselli GA; Bassani GA; Rametta R; Pietrelli A; Maggioni M; Facciotti F; Trunzo V; Badiali S; Fargion S; Gatti S; Valenti L
Clin Sci (Lond); 2017 Jun; 131(12):1301-1315. PubMed ID: 28468951
[TBL] [Abstract][Full Text] [Related]
12. Interference of selenium and selenoproteins with the insulin-regulated carbohydrate and lipid metabolism.
Steinbrenner H
Free Radic Biol Med; 2013 Dec; 65():1538-1547. PubMed ID: 23872396
[TBL] [Abstract][Full Text] [Related]
13. RORα decreases oxidative stress through the induction of SOD2 and GPx1 expression and thereby protects against nonalcoholic steatohepatitis in mice.
Han YH; Kim HJ; Kim EJ; Kim KS; Hong S; Park HG; Lee MO
Antioxid Redox Signal; 2014 Nov; 21(15):2083-94. PubMed ID: 24597775
[TBL] [Abstract][Full Text] [Related]
14. Pleiotropic actions of IP6K1 mediate hepatic metabolic dysfunction to promote nonalcoholic fatty liver disease and steatohepatitis.
Mukherjee S; Chakraborty M; Ulmasov B; McCommis K; Zhang J; Carpenter D; Msengi EN; Haubner J; Guo C; Pike DP; Ghoshal S; Ford DA; Neuschwander-Tetri BA; Chakraborty A
Mol Metab; 2021 Dec; 54():101364. PubMed ID: 34757046
[TBL] [Abstract][Full Text] [Related]
15. Hepatic oxidative stress promotes insulin-STAT-5 signaling and obesity by inactivating protein tyrosine phosphatase N2.
Gurzov EN; Tran M; Fernandez-Rojo MA; Merry TL; Zhang X; Xu Y; Fukushima A; Waters MJ; Watt MJ; Andrikopoulos S; Neel BG; Tiganis T
Cell Metab; 2014 Jul; 20(1):85-102. PubMed ID: 24954415
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte Nicotinamide Adenine Dinucleotide Phosphate Reduced Oxidase 4 Regulates Stress Signaling, Fibrosis, and Insulin Sensitivity During Development of Steatohepatitis in Mice.
Bettaieb A; Jiang JX; Sasaki Y; Chao TI; Kiss Z; Chen X; Tian J; Katsuyama M; Yabe-Nishimura C; Xi Y; Szyndralewiez C; Schröder K; Shah A; Brandes RP; Haj FG; Török NJ
Gastroenterology; 2015 Aug; 149(2):468-80.e10. PubMed ID: 25888330
[TBL] [Abstract][Full Text] [Related]
17. Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis.
Widjaja AA; Singh BK; Adami E; Viswanathan S; Dong J; D'Agostino GA; Ng B; Lim WW; Tan J; Paleja BS; Tripathi M; Lim SY; Shekeran SG; Chothani SP; Rabes A; Sombetzki M; Bruinstroop E; Min LP; Sinha RA; Albani S; Yen PM; Schafer S; Cook SA
Gastroenterology; 2019 Sep; 157(3):777-792.e14. PubMed ID: 31078624
[TBL] [Abstract][Full Text] [Related]
18. Hepatic expression of adiponectin receptors increases with non-alcoholic fatty liver disease progression in morbid obesity in correlation with glutathione peroxidase 1.
Carazo A; León J; Casado J; Gila A; Delgado S; Martín A; Sanjuan L; Caballero T; Muñoz JA; Quiles R; Ruiz-Extremera A; Alcázar LM; Salmerón J
Obes Surg; 2011 Apr; 21(4):492-500. PubMed ID: 21240660
[TBL] [Abstract][Full Text] [Related]
19. GPR40 deficiency is associated with hepatic FAT/CD36 upregulation, steatosis, inflammation, and cell injury in C57BL/6 mice.
Lu Z; Li Y; Syn WK; Li AJ; Ritter WS; Wank SA; Lopes-Virella MF; Huang Y
Am J Physiol Endocrinol Metab; 2021 Jan; 320(1):E30-E42. PubMed ID: 33103454
[TBL] [Abstract][Full Text] [Related]
20. C-type natriuretic peptide (CNP) in endothelial cells attenuates hepatic fibrosis and inflammation in non-alcoholic steatohepatitis.
Bae CR; Hino J; Hosoda H; Miyazato M; Kangawa K
Life Sci; 2018 Sep; 209():349-356. PubMed ID: 30114411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
